We provide you with 20 years of free, institutional-grade data for ISO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ISO. Explore the full financial landscape of ISO stock.
| Reported Date | CIK | Ticker | Type |
|---|
IsoPlexis Corp(NASDAQ:ISO) 
IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States and Europe. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-t...
Website: http://isoplexis.com
Founded: 2013
CEO: Sean Mackay
Sector: Healthcare
Industry: Medical Devices
Share this website to your friends
The information provided in this report about ISO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.